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A shift from papillary to reticular ﬁbroblasts enables
tumour–stroma interaction and invasion
Marieke Hogervorst1,2, Marion Rietveld1, Frank de Gruijl1 and Abdoelwaheb El Ghalbzouri1
BACKGROUND: Tumour stroma consists of a heterogeneous population of ﬁbroblasts and related mesenchymal cells, collectively
dubbed cancer-associated ﬁbroblasts (CAFs). These CAFs are key players in cancer invasion of cutaneous squamous cell carcinoma
(SCC). As we have shown earlier, papillary and reticular ﬁbroblasts (Pfs and Rfs, respectively) have distinct effects on epidermal and
dermal homeostasis, but their role in cancer invasion and epithelial-to-mesenchymal transition (EMT) remains to be determined.
METHODS:We used 3D cultures of human skin equivalents (HSEs) to analyse the effects of Pfs and Rfs on the invasive behaviour of
SCC and EMT.
RESULTS: We reveal for the ﬁrst time the importance of Pfs versus Rfs in SCC invasion and EMT. Cell lines from different stages of
SCC showed signiﬁcantly more extensive invasion into a dermis composed of Rfs than of Pfs. In addition, Rfs-based HSEs showed
increased cell activation and stained positive for CAF biomarkers α-SMA and vimentin. Further analysis revealed that invasively
growing cancer cells in Rf-HSEs express markers of EMT transition, like SNAIL2, N-cadherin and ZEB1.
CONCLUSIONS: Conversely, our results show that Pfs contain cancer cells more within the epidermis. Rfs are clearly predisposed to
differentiate into CAFs upon SCC signals, assisting invasion and EMT.
British Journal of Cancer (2018) 118:1089–1097; https://doi.org/10.1038/s41416-018-0024-y
INTRODUCTION
The crosstalk between the different components in the tumour
microenvironment is recognised as essential in cancer develop-
ment and is becoming the main focus in cancer research.1 It is
known that the tumour stroma is an integral part of cancer
development. The basement membrane (BM), immune cells,
ﬁbroblasts and extracellular matrix (ECM) surrounding the cancer
cells constitute this stroma, which actively contributes to cancer
progression.2 In cutaneous squamous cell carcinoma (SCC),
invasion occurs upon disrupted epidermal homeostasis, resulting
from interactions between the epidermal cancer cells and their
underlying stroma.3 One mechanism that facilitates SCC metas-
tasis is epithelial-to-mesenchymal transition (EMT). In epithelial
tumours, EMT is crucial for the migration and invasion of cancer
cells.4 Herein, a cell loses its epithelial phenotype and tight
cell–cell junctions and acquires a mesenchymal phenotype that
allows detachment and migration from the primary tumour into
the surrounding stroma.5 Certain ﬁbroblasts, abundant in the
tumour stroma, are associated with SCC progression; they have
structural and functional contributions to this process. These so-
called cancer-associated ﬁbroblasts (CAFs) produce growth factors
and chemokines, which facilitate angiogenesis, tissue invasion and
metastasis. In concert with epithelial cancer cells, CAFs have been
found responsible for breakdown of BM structures (by release of,
e.g., metalloproteinases) and dermal ECM remodelling, thereby
facilitating tumour invasion.6
The dermis contains a variety of ﬁbroblast exhibiting functional
diversity.7 The papillary dermis is characterised by a relatively thin
ECM combined with a high cell density, whereas the reticular ECM
has a very dense network of matrix ﬁbres and a low cell density.8
Previous studies from our group have shown that (a) papillary and
reticular ﬁbroblasts (Pf and Rf, respectively) exhibit subtype-
speciﬁc gene expression proﬁles; (b) differently affect skin
homeostasis; and that (c) Pfs can differentiate towards a reticular
phenotype by “in vitro ageing” or by transforming growth factor-β
activation.9–11 In addition, ECM generated by Pfs better supported
epidermal longevity compared to reticular-generated ECM.12
These ﬁndings indicate that Pfs and Rfs generate dissimilar ECMs
affecting skin homeostasis. For example, recently it has been
shown that initial wound healing is mediated by Rfs, while Pfs play
a crucial role in the ﬁnal stage of this process.9 These ﬁbroblast
subtypes may also affect skin-ageing processes. With ageing, the
papillary dermis gets thinner, while the reticular layer becomes
thicker.8,11 The loss of Pfs has a profound effect on skin
homeostasis as reported both in in vivo and in vitro studies.8,9
This could explain why the speed of wound closure reduces with
age.13 One may speculate that the dissimilar ECMs generated by
Pfs and Rfs also affect stroma composition that either promotes or
inhibits cancer development. To explore this hypothesis, we
examined whether (i) SCC undergoes invasion through EMT, (ii)
reticular or papillary-derived ﬁbroblasts are able to promote or
inhibit this process and (iii) Rfs differentiate towards CAFs.
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To study the clinically highly relevant effect of the ﬁbroblast
lineages abundant in the tumour stroma on invasion and early
metastasis of cutaneous SCC, we employed two types of in vitro
full-thickness skin models (FTMs): one with solely papillary dermis
(Pf-FTM) and one with a reticular dermis (Rf-FTM). Since Rfs are
different from their papillary counterparts, this causes changes in
the dermal and epidermal microenvironment that not only
contributes to skin ageing but also may affect the growth and
migrating behaviour of SCC. We investigated the behaviour and
invasive characteristics of four SCC cell lines in FTMs based on a
human ﬁbroblast‐seeded rat‐tail collagen. The cell lines were
derived from different stages of SCC. In the analysis of models, we
focused on ingrowth, epidermal hyper proliferation, activation and
differentiation, all crucial assets of invasive SCC. Furthermore, we
unravelled the mechanism causing SCC invasion in vitro, focussing
on the effect of ﬁbroblast subpopulations on EMT. In the past
decade, a repertoire of EMT biomarkers involved in metastasis of
SCC has been described.14 These biomarkers were assessed in our
in vitro SCC-FTMs. The most important factor in EMT is the
reduction of cell–cell adhesion molecule E-cadherin and upregula-
tion of more mesenchymal proteins, such as vimentin, N-cadherin
and α-smooth muscle actin (α-SMA).15 E-cadherin is, in its turn,
repressed by EMT-inducing transcription factors, like TWIST, SNAIL
and ZEB.16–18 The presented data demonstrate that ﬁbroblast
subtypes and the composition of the dermal microenvironment
play a crucial role in the invasive behaviour of SCC.
MATERIALS AND METHODS
Patient material
SCC biopsies were obtained from the archive of the Leiden
University Medical Centre pathology department. The biopsies
were either ﬁxed in 4% paraformaldehyde, dehydrated and
parafﬁn embedded or cryopreserved.
Cell culture
PFs and Rfs were isolated from different dermal layers of surplus
skin from female donors (age 31–47 years) undergoing abdominal
surgery as described earlier.8,19 Brieﬂy, the Pfs originate from a
depth of 100–300 μm; for the reticular dermis, a minimum of 700
μm is required. The different dermal layers were separated using a
dermatome. Fibroblasts were isolated from the dermis by
treatment with collagenase (Invitrogen, Breda, The Netherlands)
and dispase II (ratio 1:3 and 3ml/g dermis) (Roche Diagnostics,
Almere, The Netherlands) for 2 h at 37 °C. The cells were
subsequently ﬁltered using a 70 μm cell strainer and cultured.
Standard ﬁbroblast medium consisted of Dulbecco’s modiﬁed
Eagle’s medium (DMEM, Gibco/Invitrogen) supplemented with 5%
foetal bovine serum (FBS, HyClone/Greiner, Nurtingen, Germany
and 10mg/ml penicillin/streptomycin (Invitrogen).
For isolation of normal human epidermal keratinocytes (NHEKs),
epidermis was obtained through overnight incubation of fresh
mamma reduction surplus skin with dispase II (Roche Diagnostics,
Almere, The Netherlands). NHEKs were isolated from the
epidermis through incubation with trypsin at 37 °C for 15 min.
After trypsin inactivation, the cells were ﬁltered using a 70 μm cell
strainer (BD Biosciences, Breda, The Netherlands) and cultured in
keratinocyte medium at 37 °C and 7.3% CO2 until subconﬂuency.
Standard keratinocyte medium consisted of DMEM and Ham’s F12
medium in a 3:1 ratio, supplemented with 5% FBS, 0.28 μM
hydrocortisone, 1 mM isoproterenol, 0.87 mM insulin (Sigma-
Aldrich, Zwijndrecht, The Netherlands) and 10mg/ml penicillin/
streptomycin. All surplus material was obtained in accordance
with the Dutch Law on Medical Treatment Agreement.
SCC-12B2 (isolated from a facial SCC on a 60-year-old male
kidney transplant patient) was previously kindly provided by Dr J.
G. Rheinwald.20 SCC12b2 cells were initiated on lethally irradiated
murine 3T3 ﬁbroblasts in standard keratinocyte medium at 37 °C
and 7.3% CO2 until subconﬂuency. After a few passages, they were
cultured further without the feeder cells. The lines MET1, MET2
and MET4 cell lines were kindly provided by Professor C. Proby
(Division of Cancer Research, Medical Research Institute, Jacqui
Wood Cancer Centre Ninewell Hospital & Medical School,
Dundee).21 The MET lines were derived from the same patient,
but from an invasive (MET1), a recurrent (MET2) and metastatic
SCC (MET4). The cells were thawed and cultured in standard
keratinocyte medium supplemented with 10 ng/ml epidermal
growth factor (EGF) at 37 °C and 7.3% CO2 until subconﬂuency.
After a few passages, the EGF concentration was reduced to 2 ng/
ml.
SCC-FTM generation
Rat-tail collagen dermal matrices were constructed as described
earlier.22 Subsequently, each of the constructs were seeded with
5 × 104 SCC cells (MET1, MET2, MET4 or SCC12b2). For the co-
culture, these SCC cells were mixed with NHEKs (1:4) prior to
seeding. FTMs were incubated overnight under submerged
conditions at 37 °C and 7.3% CO2 in standard keratinocyte
medium as described above. After 3 days, FBS was reduced to
1%. Two days thereafter, FBS was omitted and human skin
equivalents (HSEs) were cultured at the air–liquid interface for
14 days. During this period, HSEs were cultured in keratinocyte
medium as described above but without serum and supplemen-
ted with 2 M l-serine, 10 mM l-carnitine, 1 μM DL-α-tocopherol-
acetate, 50 μM ascorbic acid, 2.4 × 10−5 M bovine serum albumin
and a free fatty acid supplement that contained 25 μM palmitic
Table 1. Primary antibody speciﬁcations
Antibody Clone Host Dilution Source
Collagen type IV PHM12 Mouse 1:150 Chemicon, Temecula, USA
Ki67 MIB1 Mouse 1:75 Dako, Glostrup, Germany
Keratin 17 CK-E3 Mouse 1:25 Novus Biologicals, Colorado, USA
Keratin 10 DE-K10 Mouse 1:100 Labvision/neomarkers, California, USA
Loricrin AF62 Rabbit 1:1000 Covance, USA
α-SMA 1A4 Mouse 1:400 Abcam
Laminin332 BM165 Mouse 1:75 Dr. M. Aumailley (Cologne, Germany)
ZEB1 Rabbit 1:666 Atlas antibodies
B-cat 14/Beta-Catenin Mouse 1:250 BD Bioscience
TGM2 CUB7402 Mouse 1:50 Abcam
PDPN 18H5 Mouse 1:100 Abcam
TNC EPR4219 Rabbit 1:100 GeneTex
Reticular ﬁbroblasts conductive to SCC invasion
M. Hogervorst et al.
1090
1
2
3
4
5
6
7
8
9
0
()
;,:
acid, 30 μM linoleic acid and 7 μM arachidonic acid (Sigma-
Aldrich). Culture medium was refreshed twice a week.
Morphological and immunohistochemical (IHC) analysis
From the HSEs, one part was snap-frozen in liquid nitrogen while
the other part was ﬁxed in 4% paraformaldehyde, dehydrated and
parafﬁn embedded. Global histological analysis was performed on
5 μm sections through haematoxylin and eosin (HE) staining.
Immunohistochemical analysis was performed using the
streptavidin–biotin–peroxidase system (GE Healthcare, Buckin-
ghamshire, UK), according to the manufacturer’s instructions.
Staining was visualised with 3-amino-9-ethylcarbazole, counter-
stained with haematoxylin and mounted with Kaiser’s glycerine.
For antigen retrieval, sections were boiled in citrate buffer (pH 6.0)
in an autoclave at 110 °C for 5 min (for ki67, k16, k17, k10 and
loricrin) or incubated with 0.025% protease-X (Sigma, Zwijndrecht,
The Netherlands) at 37 °C for 40min (for collagen type IV). For
ﬂuorescence staining, sections were labelled with the primary
antibody as described above and counterstaining was performed
with 4,6-diamidino-2-phenylindole. Primary antibodies are speci-
ﬁed in Table 1.
Secondary antibodies included biotinylated goat anti-mouse
IgG secondary antibody (Dako, Glostrup, Germany), swine anti-
rabbit igG secondary antibody (Dako, Glostrup, Germany),
biotinylated goat anti-mouse IgG secondary antibody (Jackson)
and goat anti-rabbit Alexa 488 (Invitrogen).
Quantiﬁcation of ingrowth
Pictures of the HE staining were converted to greyscale. In the
program Image J, boundaries were set manually along the
ingrowth areas of the HSEs. Subsequently, the inverse average
intensity per pixel was multiplied by the area. Results were
expressed as the mean ± SD of the four counts in three different
donors (error bars).
Quantiﬁcation of proliferation index
To determine the proliferation index of the FTMs cultured with
SCC cells, the number of Ki67-positive nuclei from a total number
of 100 basal epidermal cells was determined. Per section, counts
were performed in three different locations at a magniﬁcation of
200×. Results were expressed as the mean ± SD of the three
counts in three donors (error bars).
RNA isolation and quantitative PCR (qPCR)
At harvesting, the FTMs was cut into small fragments and diluted
in a β-mercaptoethanol solution. RNA was isolated from the whole
FTM (dermis and epidermis) with the RNEasy Kit (Qiagen, Venlo,
The Netherlands). Sufﬁcient amounts of total RNA were available
for cDNA synthesis using the iScript™ cDNA Synthesis Kit (Bio-
Rad, Veenendaal, The Netherlands) according to the manufac-
turer’s instructions. Primers (Invitrogen, Breda, The Netherlands)
were designed for genes of interest and three reference
genes (Table 2). qPCR reactions were performed using the SYBR
Green Supermix (Bio-Rad) on the CFX384™ real-time PCR
detection system (Bio-Rad). The PCR program included initialisa-
tion (6 min at 95 °C), 45 cycles of denaturation (15 s at 95 °C),
annealing (30 s at 60 °C) and elongation (30 s at 72 °C), ﬁnal
elongation for 1 min at 72 °C and a DNA melting curve (from 55 °C
to 95 °C through 0.2 °C increments every 10 s). All samples were
tested in duplicate. Speciﬁcity of PCR products was evaluated by
size in agarose gel electrophoresis followed by DNA sequence
analysis. Serial dilutions of cDNA from spontaneously immortalised
keratinocytes (own laboratory) and universal human reference
RNA (Stratagene, Santa Clara, CA, USA) were included to
determine PCR efﬁciencies.
Table 2. qPCR primers
Gene Forward primer 5ʹ→ 3ʹ Reverse primer 5ʹ→ 3ʹ
Genes of interest
SERPINB4 CAAAGGGCAGTGGGAGAATA CCTCCAGCAAGGCAAAATTA
MMP9 CCTGGAGACCTGAGAACCAA ATTTCGACTCTCCACGCATC
SNAI2 ACAAGCAGCTGCACTGTGAT ACACAAGGCAATGTGTGGGT
ASMA GTGTTGCCCCTGAAGAGCAT GCTGGGACATTGAAAGTCTCA
N-cadherin TCATTGCCATCCTGCTCTGCAT AGTTGTTTGGCCTGGCGTTCTT
Reference genes
RPS29 TATGTGCCGCCAGTGTTTCC TGCCCCGGATAATCCTCTGA
ZNF410 GCTGTGGTAAGCAGTTTACTACAG CTTGGGCTTCACAAAGGAAAGG
TGM2 PDPN
TNC
Vimentin ZEB1
100 μm
α-SMA
Fig. 1 Immunoﬂuorescent and immunohistochemical analysis of
vimentin, ZEB1 (green)/β-catenin (red), TGM2, α-SMA, PDPN and TCN
expression in SCC biopsy cross sections (N= 8) Arrows in PDPN
panel point at papillary ﬁbroblasts, those in the alpha-SMA at
evident CAFs, and in the vimentin and ZEB1 panels at EMT of
tumour cells.
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Local ethic board approval for the study and informed consent
All primary human skin cells from healthy donors used by the
Department of Dermatology are isolated from surplus tissue
collected according to article 467 of the Dutch Law on Medical
Treatment Agreement and the Code for proper Use of Human
Tissue of the Dutch Federation of Biomedical Scientiﬁc Societies.
According to article 467, surplus tissue can be used if no objection
is made by the patient. This means that the patient who will
undergo plastic surgery is well informed on the research. In case
he/she refuses, the patient has to sign the inform consent form; if
they agree, they do not sign. This approach differs from other
countries. None of the authors were involved in the tissue
sampling and only birth date, gender and skin type of the subjects
was known. The Declaration of Helsinki principles were followed
when working with human tissue.
RESULTS
Fibroblast heterogeneity in SCC tumour stroma
We examined the presence of Pfs and Rfs and EMT-related
biomarkers in SCC skin biopsies (N = 8). TGM2 for reticular and
PDPN and TCN for Pfs were analysed by IHC. As shown in Fig. 1,
ﬁbroblasts expressing TGM2 were observed throughout the
tumour stroma, while the expression of PDPN and TNC is lower
and more restricted. Additionally, we stained for α-SMA, a speciﬁc
biomarker for myoﬁbroblasts or CAFs, vimentin, a biomarker for
mesenchymal cells and ZEB1, a biomarker for EMT. As shown in
Fig. 1, a subset of ﬁbroblasts clearly stained positive for α-SMA in
the activated stroma, while vimentin and ZEB1 expression was
found in the mesenchymal cells surrounding malignant cells.
In vitro effect of ﬁbroblast subpopulations on SCC invasion
Next we examined the effect of Rfs and Pfs on the invasive
behaviour of SCC using FTMs that are generated with a dermal
matrix comprising Rfs (Rf-FTMs) or Pfs (Pf-FTMs). To this end, we
measured the ingrowth of the different SCC cell lines in HE-stained
FTMs (Fig. 2a). As indicated in the ﬁgure, in Pf-FTMs onto which
different MET cell lines were seeded, no-to-minimal ingrowth was
observed in the dermal matrix, while in Rf-FTMs the different MET
cell lines had migrated into the dermis. SCC12b2 shows migration
in both the papillary and the reticular dermis, but this effect is
stronger in the Rf-FTMs as shown in Fig. 2b. Quantiﬁcation of the
migrated areas revealed that the different MET cell lines 1 and 2
and SCCb12 show a signiﬁcantly higher migration in Rf-FTMs than
in Pf-FTMs.
Subsequently, we further characterised these FTMs on epider-
mal morphogenesis comprising biomarkers for cell activation, BM
formation, cell proliferation and differentiation using IHC or
immunoﬂuorescence analyses.
To assess cell activation in Rf-FTMs and Pf-FTMs, we examined
K16 (hyperproliferation-speciﬁc keratin) expression. As demon-
strated in Fig. 3a, K16 is expressed (mostly supra-basal) in all FTMs
irrespective of the composition of the dermal matrix, indicating an
increased cell activation. However, in Rf-FTMs its expression seems
more pronounced. The BM plays an important role in cancer
invasion since it acts as a mechanical barrier preventing malignant
cells from invading the dermis and deeper tissue. BM formation
and integrity was assessed by the expression of ColIV, an
important BM protein located at the epidermal–dermal junction
(EDJ). In addition, BM homeostasis was assessed by IHC staining of
laminin332, appearing as a thin line at the EDJ, indicating the
presence of a functional BM (Fig. 3a). In Pf-FTMs, the BM forms a
proper barrier between the dermis and the epidermis. However,
the Rf-FTMs show disruption of the BM, lining the ingrowth areas
in the dermal compartment. Figure 3b shows abundant proliferat-
ing cells in the ingrowth areas of the FTMs. By cell count, the
percentage of proliferating cells per FTM per area was calculated,
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Fig. 2 a Cross-sections of Pf-FTMs and Rf-FTMs (HE). The epidermis was generated using MET1, MET2, MET4 or SCC12b2 SCC cell lines. b
Quantiﬁcation of the ingrowth; the ingrowth is signiﬁcantly higher in Rf-FTMs of MET1 (P< 0.005), MET2 (P< 0.0001) and SCC12b2 (P< 0.05);
N= 3
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which showed more proliferation in the Rf-FTMs compared to that
in the Pf-FTMs.
EMT-related biomarkers abundantly expressed in Rf-FTMs
In response to the clear inﬂuence of the ﬁbroblast subpopulations
on SCC ingrowth in Rf-FTMs, further experiments were conducted
to unravel the underlying mechanism. EMT-speciﬁc biomarkers
were detected by gene expression and conﬁrmed on protein level.
Gene expression analysis revealed clear trends in SCC-FTMs
derived from three Rf and Pf donors, shown in Figure 4. α-SMA,
SNAI2 and N-cadherin, three essential biomarkers for EMT, were
overexpressed in Rf-FTMs. Also, matrix metalloproteinase 9
(MMP9), a metalloproteinase responsible for breakdown of the
BM in tumour invasion, is strongly upregulated in the Rf-FTMs.
However SerpinB4, an important SCC biomarker, is more highly
expressed in the Pf-FTMs.
Increased vimentin expression is frequently used as an EMT
marker in cancer. In Fig. 5, vimentin is visible in both ﬁbroblasts
types and clearly in cells between the epithelium and the
ingrowth areas, as indicated by the arrows. An increased
expression in the Rf-FTM is visible, with the strongest signal in
the MET1 and MET2 Rf-FTMs. At this exact same localisation
α-SMA is expressed. α-SMA is both an important EMT and CAF
marker found in the reactive tumour stroma. The increased α-SMA
gene expression in Rf-FTMs is hereby conﬁrmed on the protein
level.
This correlates to the expression of ZEB1, also shown in Fig. 5.
Transcription factor ZEB1 induces EMT by downregulating
E-cadherin and upregulating a number of other mesenchymal
markers, e.g., vimentin, thereby facilitating cell migration and
invasion. More ZEB1 expression is visible in the Rf-FTMs, especially
in MET1 and MET2 SCC cells appearing at the same localisation as
the vimentin- and α-SMA-positive cells.
DISCUSSION
Characterisation of SCC in vitro and effects of ﬁbroblast
subpopulations on SCC progression
Examination of the tumour stroma in SCC biopsies showed a
dynamic and diverse landscape of ﬁbroblast lineages surrounding
malignant cells. By insulating Pfs and Rfs in the in vitro SCC-FTMs,
we investigated the role of ﬁbroblast subtypes in the tumour
microenvironment on SCC behaviour and possibly EMT-like
mechanisms. In this study, it is demonstrated for the ﬁrst time
that Pf and Rf subtypes strongly inﬂuence the tumour stroma and
thereby contribute to SCC invasion. Pfs contain the cancer cells
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Fig. 3 a Cross-sections of Pf-FTMs and Rf-FTMs stained for K16, collagen type IV, laminin 332 and Ki67. The epidermis was generated with
MET1, MET2, MET4 or SCC12b2 cell lines. Data are obtained for three independent experiments. b Quantiﬁcation of Ki67 in FTMs seeded with
MET1, MET2 and MET4. Results are expressed as the mean± SD of three counts in three donors (*<0.05)
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within the epidermis, while Rfs are clearly predisposed to
differentiate into CAFs upon SCC signals, assisting invasion and
initiating EMT. We reconﬁrmed these observations in another set
of experiments in which we mixed the different SCC cell lines with
NHEKs (ratio 1:4) and evaluated the expression of the early (K10)
and late differentiation (loricrin) proteins in both FTM models
(supplementary ﬁgure 1). The tumour stroma is an integral part of
cancer progression.23 Individual components of the stroma, in
particular CAFs, play an important role in these processes.24
Insights have emerged regarding communication between
ﬁbroblasts and epidermal cells.25 Signalling molecules, released
by ﬁbroblasts, inﬂuence keratinocyte migration, proliferation and
differentiation, all of which are key elements in SCC develop-
ment.26–28 This communication between malignant cells and their
environment is modelled and demonstrated in vitro.
FTMs mimic SCC behaviour
The effect of the Pf and Rf subtypes on SCC ingrowth was striking.
The measurements showed signiﬁcantly more migration of
malignant cells into the dermis in Rf-FTMs compared to that in
Pf-FTMs. In this study, the models are examined for their SCC
characteristics, and further on, the mechanism behind this
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phenomenon is unravelled. In healthy skin, proliferation and
differentiation of epidermal keratinocytes is tightly controlled to
ensure proper development and homeostasis of the epidermis. In
SCC, homeostasis is completely disrupted. This phenomenon is
also observed in our FTMs that were generated with a reticular
dermis.
In the epidermis, K16 and K17 expression is absent under
normal conditions. K16 and K17 are induced during wound
healing where the skin shows hyperproliferation and aberrant
differentiation.29,30 This induction correlates with the onset of
keratinocyte activation, and therefore, it is hypothesised that these
keratins are involved in the process of SCC.31,32 In a previous study
from our group, we have shown that K16 and K17 were listed in
the top three genes that was signiﬁcantly upregulated in actinic
keratosis and SCCs and could hereby be used as a biomarker for
this epithelial cancer.33 Expression of both K16 and K17 (data not
shown) was more pronounced in Rf-FTMs generated with MET 1
and 4 when compared to Pf-FTMs. One may speculate that this
difference may be explained by the different stages of the SCC cell
lines. Malignant cells often harbour an increased cell proliferation.
Detection of the cell‐cycling-speciﬁc marker Ki67 showed more
cell proliferation in the reticular models of MET1, MET2 and MET4.
With these ﬁndings, we can conﬁrm that the cell lines show typical
SCC progression on FTMs, but this phenotype is more pronounced
in the Rf-FTMs.
The BM is the ﬁrst and most robust structural barrier to
invasion.34 In the normal skin, the BM separates epithelium from
the underlying connective tissue, the dermis. After destruction of
the BM, tumour cells invade locally or metastasise to distant
sites.14 To evaluate BM formation, expression of collagen type IV
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Fig. 5 Shown are cross-sections of Pf-FTMs and Rf-FTMs that were stained for vimentin, α-SMA and ZEB/β-catenin. The epidermis was
generated with MET1, MET2, MET4 or SCC12b2 cell lines. Arrows indicate the expression of these biomarkers surrounding the SCC ingrowth.
Data are obtained for three independent experiments
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and laminin332 in FTMs was assessed. Many of the key elements
of the BM, including collagen type IV, have been shown to be
dysregulated in SCC.35 In conventional FTMs, the BM is formed in a
comparable way as in the in vivo situation and shares the same
characteristics. In the Pf-FTMs, collagen type IV and laminin332
were evenly distributed along the BM, separating the dermis from
the epidermis. In the reticular models, we noticed a disruption of
the BM, framing the ingrowth areas in the dermis, where we
observe cell islands. However, when modelling invasion, the BM
should be ﬁrst fully formed and functional before any invasion in
underlying connective tissue may proceed.22
Rf-FTMs are prone to EMT
A crucial set of EMT markers was selected and evaluated at the
gene and protein expression level. Gene expression analysis
showed an overexpression of certain EMT biomarkers among all
donors. Transcription factors responsible for EMT are ZEB1, SNAI
and TWIST.36 An overexpression of SNAI2 is shown in Rf-FTMs,
together with an upregulation of the cell-surface protein
N-cadherin, which correlates with high risk of SCC invasion via
EMT-like mechanisms.37 In SCC, the tumour tissue is surrounded
by reactive stroma, made up mostly of CAFs, known for their
expression of α-SMA. This expression is related to the stage of
tumour development and patient prognosis.38 In Rf-FTMs, a strong
upregulation (2–15-fold) of α-SMA mRNA is shown; in further
analysis, this upregulation is conﬁrmed at the protein level by IHC.
The ﬁbroblasts in Rf-FTMs express α-SMA when they are localised
near the malignant SCC cells, meaning activation of the stroma.
Cells positive for α-SMA contribute to EMT by their increased
contractile mobility and ECM remodelling ability.3 Importantly,
since in normal Pf-FTMs or Rf-FTMs no cells stain positive for
α-SMA (data not shown), one may infer that Rfs differentiate into
CAFs due to factors secreted by the MET cell lines. This hypothesis
is strengthened by an increased expression of vimentin and ZEB1
at the same spots as the α-SMA-positive cells, indicating signalling
between the SCC cells and their surrounding stroma. Cytoskeletal
protein vimentin is used to distinguish mesenchymal cells from
epithelial cells. It is abundantly expressed in ﬁbroblasts. When cells
undergo EMT, they adopt a mesenchymal phenotype where
vimentin is expressed at the sites of cellular elongation.39
Observed ZEB1 contributes to malignant progression by upregu-
lation of N-cadherin, vimentin and MMPs and is therefore an
important EMT inducer.15
Among the most commonly identiﬁed metalloproteinases in
SCC is MMP9.40,41 MMP9 is a gelatinase, which degrades collagen
type IV, most critical in degradation of the BM. We show
upregulation of MMP9 in Rf-FTMs, compared to Pf-FTMs. MMPs
were initially thought to be produced solely by the tumour cell,
but further investigation has also shown production by CAFs and
the surrounding inﬂammatory cells.41 Recently, it has been shown
that MMP9 could even lead to activation of EMT genes.42,43 In this
way, it is plausible that the tumour stroma consisting of Rfs is
involved in MMP9 upregulation and facilitate SCC invasion via
EMT.
SerpinB4 is described as a biomarker of cancer and known to be
strongly upregulated in SCC indicative of a poor prognosis.44,45
Although the process is not yet fully understood, SerpinB4 also
acts as an EMT promoter.46 It is expressed by both epithelial cells
and ﬁbroblasts upon oncogenic Ras activation.47 Interestingly, in
this study SerpinB4 is strongly upregulated in the Pf-FTMs. This
seems inconsistent with the literature so far. However, it could also
be one of the important features of the possible protective
function of the papillary dermis that may give new insights in the
inﬂuences on the tumour stroma.
In this study, we show for the ﬁrst time that a functional link
exists between the two ﬁbroblasts subtypes in the dermis and
invasive behaviour of SCC. Rfs and Pfs create distinct tumour
microenvironments that differently affect SCC progression. Where
the reticular dermis forms a tumour-promoting environment, the
papillary dermis protects against tumour invasion. Pfs can
differentiate into Rfs after in vitro ageing (prolonged culture)
and Rfs could then be the precursors of CAFs since they are
predisposed to differentiate or be 'activated' after interaction with
the tumour.12 This differentiation or 'activation' process may be
also valid for different ﬁbroblast subtypes with other types of
epithelial cancers.
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